Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis

From BugSigDB
Reviewed Marked as Reviewed by Peace Sandy on 2024-1-18
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Kitae H, Takagi T, Naito Y, Inoue R, Azuma Y, Torii T, Mizushima K, Doi T, Inoue K, Dohi O, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Konishi H, Itoh Y
Journal
Microorganisms
Year
2022
Keywords:
LEfSe, fecal microbiota, quiescent ulcerative colitis, ulcerative colitis relapse
The microbiota associated with relapse in patients with quiescent ulcerative colitis (qUC) remains unclear. Our objective was to analyze the fecal microbiota of Japanese patients with qUC and identify the relapse-associated microbiota. In this study, 59 patients with qUC and 59 healthy controls (HCs) were enrolled (UMIN 000019486), and their fecal microbiota was compared using 16S rRNA gene amplicon sequencing. We followed their clinical course up to 3.5 years and analyzed the relapse-associated microbiota. Potential functional changes in the fecal microbiota were evaluated using PICRUSt software and the Kyoto Encyclopedia of Genes and Genomes database. There were significant differences in fecal microbiota diversity between HC and qUC subjects, with 13 taxa characterizing each subject. Despite no significant difference in variation of microbiota in a single sample (α diversity) between patients in sustained remission and relapsed patients, the variation in microbial communities between samples (β diversity) was significantly different. Prevotella was more abundant in the sustained remission patients, whereas Faecalibacterium and Bifidobacterium were more abundant in the relapsed patients. We clustered the entire cohort into four clusters, and Kaplan-Meier analysis revealed the subsequent clinical course of each cluster was different. We identified 48 metabolic pathways associated with each cluster using linear discriminant analysis effect size. We confirmed the difference in microbiota between patients with qUC and HCs and identified three genera associated with relapse. We found that the clusters based on these genera had different subsequent clinical courses and activated different metabolic pathways.

Experiment 1


Reviewed Marked as Reviewed by Peace Sandy on 2024-1-18

Curated date: 2023/12/12

Curator: Yjung24

Revision editor(s): Yjung24

Subjects

Location of subjects
Japan
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Ulcerative colitis colitis ulcerative,Colitis, Ulcerative,Left-sided ulcerative (chronic) colitis,Left-sided ulcerative colitis,left-sided ulcerative colitis,Other ulcerative colitis,Other ulcerative colitis (disorder),UC - ulcerative colitis,ulcerative colitis,ulcerative colitis (disease),ulcerative colitis (disorder),Ulcerative colitis, unspecified,ULCERATVE COLITIS UNSPCF,Ulcerative colitis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
healthy controls
Group 1 name Corresponds to the case (exposed) group for case-control studies
quiescent ulcerative colitis patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
consecutive recruitment of patients with quiescent UC in our outpatient clinic from November 2016 to September 2017. Clinical remission was defined as a Lichtiger index score of ≤4.
Group 0 sample size Number of subjects in the control (unexposed) group
59
Group 1 sample size Number of subjects in the case (exposed) group
59
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
no history of antibiotic use within three months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
4
Matched on Factors on which subjects have been matched on in a case-control study
age, sex

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
decreased
Chao1 Abundance-based estimator of species richness
decreased
Richness Number of species
decreased

Signature 1

Reviewed Marked as Reviewed by Peace Sandy on 2024-1-18

Curated date: 2023/12/12

Curator: Yjung24

Revision editor(s): Yjung24, Peace Sandy

Source: Figure 1f

Description: linear discriminant analysis effect size (LEfSe) analysis identified taxa that characterized each group. Cladogram of LEfSe analysis results. Yellow-shaded areas indicate taxa that characterize UC, and green-shaded areas indicate taxa that characterize HCs. Linear discriminant analysis (LDA) scores for identified taxa of patient of UCs (7 taxa) and HC (6 taxa) was shown. ** p < 0.01.

Abundance in Group 1: increased abundance in quiescent ulcerative colitis patients

NCBI Quality ControlLinks
Acidimicrobiia
Actinomycetota
Bacilli
Bifidobacteriaceae
Bifidobacteriales
Bifidobacterium
Lactobacillales

Revision editor(s): Yjung24, Peace Sandy

Signature 2

Reviewed Marked as Reviewed by Peace Sandy on 2024-1-18

Curated date: 2023/12/12

Curator: Yjung24

Revision editor(s): Yjung24, Peace Sandy

Source: Figure 1f

Description: linear discriminant analysis effect size (LEfSe) analysis identified taxa that characterized each group. Cladogram of LEfSe analysis results. Yellow-shaded areas indicate taxa that characterize UC, and green-shaded areas indicate taxa that characterize HCs. Linear discriminant analysis (LDA) scores for identified taxa of patient of UCs (7 taxa) and HC (6 taxa) was shown. ** p < 0.01.

Abundance in Group 1: decreased abundance in quiescent ulcerative colitis patients

NCBI Quality ControlLinks
Bacteroidales
Bacteroidia
Bacteroidota
Clostridia
Eubacteriales

Revision editor(s): Yjung24, Peace Sandy

Experiment 2


Reviewed Marked as Reviewed by Peace Sandy on 2024-1-18

Curated date: 2023/12/12

Curator: Yjung24

Revision editor(s): Yjung24

Differences from previous experiment shown

Subjects

Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Disease progression measurement Disease progression measurement,disease progression measurement
Group 0 name Corresponds to the control (unexposed) group for case-control studies
sustained remission of ulcerative colitis group
Group 1 name Corresponds to the case (exposed) group for case-control studies
relapsed ulcerative colitis group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Patients who had clinically relapsed during the 3.5 year-long follow-up period. Clinical relapse was defined as clinical or endoscopic deterioration requiring therapeutic modification.
Group 0 sample size Number of subjects in the control (unexposed) group
40
Group 1 sample size Number of subjects in the case (exposed) group
19
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
Not specified

Lab analysis

Statistical Analysis

Matched on Factors on which subjects have been matched on in a case-control study
Not specified

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged
Richness Number of species
unchanged

Signature 1

Reviewed Marked as Reviewed by Peace Sandy on 2024-1-18

Curated date: 2023/12/12

Curator: Yjung24

Revision editor(s): Yjung24, Peace Sandy

Source: Figure 2g

Description: linear discriminant analysis effect size (LEfSe) analysis identified taxa that characterized each group. Cladogram of LEfSe analysis results. Red-shaded areas indicate taxathat characterize relapse group, and blue-shaded areas indicate taxa that characterize SusRem group. Linear discriminant analysis (LDA) scores for identified taxa of SusRem (2 taxa) and Relapse (6 taxa)

Abundance in Group 1: increased abundance in relapsed ulcerative colitis group

NCBI Quality ControlLinks
Acidimicrobiia
Actinomycetota
Bifidobacteriaceae
Bifidobacteriales
Bifidobacterium
Faecalibacterium

Revision editor(s): Yjung24, Peace Sandy

Signature 2

Reviewed Marked as Reviewed by Peace Sandy on 2024-1-18

Curated date: 2023/12/12

Curator: Yjung24

Revision editor(s): Yjung24, Peace Sandy

Source: Figure 2g

Description: linear discriminant analysis effect size (LEfSe) analysis identified taxa that characterized each group. Cladogram of LEfSe analysis results. Red-shaded areas indicate taxa that characterize relapse group, and blue-shaded areas indicate taxa that characterize SusRem group. Linear discriminant analysis (LDA) scores for identified taxa of SusRem (2 taxa) and Relapse (6 taxa)

Abundance in Group 1: decreased abundance in relapsed ulcerative colitis group

NCBI Quality ControlLinks
Prevotella
Prevotellaceae

Revision editor(s): Yjung24, Peace Sandy